Correction to: Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer. Matrone A, Prete A, Nervo A, Ragni A, et al. J Endocrinol Invest 2021 Jun 5. pii: 10.1007/s40618-021-01592.

Read + Share

Amedeo Smart

Independent Medical Education

Matrone A, Prete A, Nervo A, Ragni A, et al. Correction to: Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer. J Endocrinol Invest 2021 Jun 5. pii: 10.1007/s40618-021-01592.
PMID: 34089498